Alcon, Cooper, Medtronic company shares with long positions
2022.12.22 13:45
Alcon, Cooper, Medtronic company shares with long positions
Budrigannews.com – In a note on stocks of medtech and diagnostics on Thursday, Mizuho analysts stated that Alcon (NYSE:), The Cooper Companies as well as Medtronic (NYSE:
In the memo to clients, the analysts said that they expect many of the same trends from this year to continue into 2023, such as “1) hospital health, 2) fears of a recession, and 3) inflation.”
On the other hand, they are of the opinion that the “pump feels primed for several tailwinds that could drive valuations higher,” which include increased procedure volumes, a larger-scale merger and acquisition, and the reemergence of the IPO market.
“We are launching coverage on Alcon (ALC, $85) and Cooper Companies (COO, $375) at Buy with both ratings reflecting the benefits to ophthalmology proving relatively more insular to other areas of Medtech in prior recessions coupled with benefits of recent/ongoing product launches providing tailwinds into next year,” the analysts added. “We are launching coverage on Alcon (ALC, $85) and Cooper Companies (COO, $375) at Buy.”
More CAC 40 index lost 1% by close
“Given that we see: Our preferred large-cap names are ALC, COO, and MDT,” New product launches (such as RDN, IOP drops, and MiSight), exposure to high-growth end markets (such as Glaucoma, TAVR, LAA, and robotics), and [4] multiple R&D shots-on-goal over the next three years are all important.
